| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
27,414 |
25,139 |
$3.05M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,307 |
14,368 |
$1.83M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,783 |
2,367 |
$957K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,434 |
4,647 |
$729K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,619 |
3,028 |
$572K |
| 80053 |
Comprehensive metabolic panel |
56,016 |
44,703 |
$553K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,601 |
3,679 |
$522K |
| J3490 |
Unclassified drugs |
120,901 |
44,922 |
$428K |
| A0430 |
Ambulance service, conventional air services, transport, one way (fixed wing) |
156 |
139 |
$384K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,262 |
2,659 |
$365K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
14,221 |
10,747 |
$250K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
9,160 |
3,110 |
$250K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
73,598 |
57,521 |
$232K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,523 |
1,294 |
$201K |
| 71046 |
Radiologic examination, chest; 2 views |
6,581 |
5,164 |
$192K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,716 |
4,027 |
$171K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,370 |
2,119 |
$157K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,792 |
1,242 |
$156K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,679 |
811 |
$144K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
18,667 |
15,380 |
$143K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
18,014 |
14,578 |
$133K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,733 |
4,041 |
$131K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,737 |
1,650 |
$102K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,437 |
5,497 |
$95K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
275 |
224 |
$94K |
| 76830 |
Ultrasound, transvaginal |
906 |
754 |
$94K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,176 |
1,469 |
$84K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,393 |
1,301 |
$84K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,255 |
6,248 |
$79K |
| 80320 |
|
1,131 |
963 |
$78K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
880 |
457 |
$74K |
| 96376 |
|
2,618 |
1,741 |
$62K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
939 |
784 |
$60K |
| 84484 |
|
4,176 |
2,640 |
$58K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,550 |
1,615 |
$55K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
832 |
549 |
$55K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,720 |
3,953 |
$54K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,633 |
1,514 |
$51K |
| A0431 |
Ambulance service, conventional air services, transport, one way (rotary wing) |
29 |
25 |
$48K |
| 36415 |
Collection of venous blood by venipuncture |
23,975 |
19,343 |
$48K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
116 |
88 |
$47K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
522 |
462 |
$47K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,281 |
1,163 |
$47K |
| 87653 |
|
1,262 |
1,114 |
$47K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,502 |
2,504 |
$46K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
138 |
117 |
$45K |
| 86780 |
|
2,304 |
2,012 |
$42K |
| 81001 |
|
14,373 |
11,505 |
$42K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,091 |
967 |
$39K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
112 |
105 |
$39K |
| 80061 |
Lipid panel |
3,115 |
2,763 |
$39K |
| 72100 |
|
799 |
647 |
$39K |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
2,305 |
2,026 |
$38K |
| 90715 |
|
596 |
498 |
$37K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
3,114 |
2,769 |
$36K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
212 |
79 |
$32K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
570 |
395 |
$32K |
| 87536 |
|
441 |
389 |
$31K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,548 |
2,300 |
$30K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
176 |
161 |
$30K |
| 83690 |
|
8,728 |
6,964 |
$29K |
| 86762 |
|
1,337 |
1,131 |
$27K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,106 |
532 |
$26K |
| 80329 |
|
672 |
576 |
$25K |
| 87340 |
|
1,926 |
1,686 |
$25K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
84 |
74 |
$23K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
961 |
893 |
$22K |
| 81025 |
|
3,287 |
2,601 |
$21K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
932 |
796 |
$20K |
| 73030 |
|
669 |
545 |
$20K |
| 86850 |
|
2,349 |
1,927 |
$20K |
| 84702 |
|
1,967 |
1,236 |
$20K |
| 84439 |
|
2,050 |
1,779 |
$19K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
89 |
78 |
$19K |
| 71045 |
Radiologic examination, chest; single view |
4,286 |
3,709 |
$19K |
| 86140 |
|
1,731 |
1,482 |
$18K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
57 |
50 |
$18K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
3,367 |
1,427 |
$18K |
| 73630 |
|
638 |
507 |
$16K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
932 |
796 |
$16K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
902 |
668 |
$15K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,163 |
1,100 |
$15K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,618 |
5,281 |
$15K |
| 85610 |
|
4,641 |
3,408 |
$14K |
| 82570 |
|
1,455 |
1,131 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,120 |
2,470 |
$13K |
| 76801 |
|
154 |
111 |
$13K |
| J7050 |
Infusion, normal saline solution, 250 cc |
11,252 |
5,560 |
$13K |
| 82728 |
|
1,003 |
919 |
$12K |
| 73562 |
|
449 |
349 |
$12K |
| 73610 |
|
470 |
345 |
$12K |
| 73130 |
|
445 |
341 |
$10K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
160 |
115 |
$10K |
| 97161 |
|
70 |
68 |
$10K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,211 |
6,078 |
$9K |
| 85027 |
|
2,099 |
1,580 |
$9K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
92 |
79 |
$8K |
| 87081 |
|
553 |
481 |
$8K |
| 87186 |
|
1,055 |
884 |
$8K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,905 |
2,580 |
$8K |
| 80306 |
|
1,339 |
1,182 |
$8K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
809 |
565 |
$8K |
| 83540 |
|
1,047 |
949 |
$8K |
| 83550 |
|
999 |
909 |
$7K |
| 82565 |
|
2,880 |
2,510 |
$7K |
| 70498 |
|
17 |
13 |
$7K |
| 76770 |
|
52 |
32 |
$7K |
| 76642 |
|
85 |
70 |
$7K |
| 86900 |
|
2,401 |
1,954 |
$6K |
| 86901 |
|
2,404 |
1,954 |
$6K |
| 87088 |
|
652 |
569 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,690 |
6,769 |
$6K |
| 82607 |
|
484 |
415 |
$5K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
550 |
431 |
$5K |
| 83735 |
|
999 |
706 |
$5K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,130 |
1,690 |
$5K |
| 82962 |
|
3,923 |
1,611 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
11,349 |
9,435 |
$5K |
| 83880 |
|
186 |
152 |
$5K |
| 83605 |
|
516 |
356 |
$5K |
| 85379 |
|
480 |
415 |
$4K |
| 96367 |
|
157 |
111 |
$4K |
| 84156 |
|
708 |
477 |
$4K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,750 |
2,628 |
$4K |
| 85652 |
|
1,438 |
1,202 |
$4K |
| 82950 |
|
780 |
696 |
$4K |
| 97162 |
|
161 |
140 |
$3K |
| 76536 |
|
30 |
24 |
$3K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
43 |
42 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,214 |
2,699 |
$3K |
| 36591 |
|
200 |
125 |
$3K |
| 83615 |
|
644 |
400 |
$3K |
| 83516 |
|
119 |
109 |
$3K |
| 87070 |
|
292 |
231 |
$2K |
| 70496 |
|
14 |
12 |
$2K |
| 88342 |
|
124 |
108 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,630 |
2,715 |
$2K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,486 |
1,091 |
$2K |
| 73110 |
|
86 |
69 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
27 |
25 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,347 |
1,836 |
$2K |
| 82947 |
|
1,073 |
757 |
$2K |
| 80076 |
|
401 |
347 |
$2K |
| 80325 |
|
17 |
12 |
$2K |
| 85730 |
|
459 |
358 |
$2K |
| 82670 |
|
214 |
173 |
$2K |
| 87147 |
|
345 |
248 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
132 |
84 |
$2K |
| J2560 |
Injection, phenobarbital sodium, up to 120 mg |
137 |
104 |
$2K |
| 82784 |
|
94 |
68 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
749 |
465 |
$1K |
| 88304 |
|
46 |
37 |
$1K |
| 97163 |
|
27 |
26 |
$1K |
| 73502 |
|
40 |
37 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
3,067 |
2,325 |
$1K |
| 84550 |
|
344 |
208 |
$1K |
| 84481 |
|
93 |
70 |
$1K |
| 80359 |
|
17 |
12 |
$1K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
422 |
361 |
$1K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
2,749 |
2,042 |
$1K |
| 74018 |
|
26 |
25 |
$1K |
| 82043 |
|
27 |
25 |
$942.62 |
| A0425 |
Ground mileage, per statute mile |
24 |
24 |
$870.84 |
| 86360 |
|
32 |
25 |
$854.63 |
| 87205 |
|
227 |
175 |
$837.31 |
| 86359 |
|
32 |
25 |
$834.42 |
| 84703 |
|
685 |
618 |
$823.66 |
| 87040 |
|
105 |
49 |
$704.16 |
| J1630 |
Injection, haloperidol, up to 5 mg |
2,247 |
1,763 |
$645.67 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,304 |
853 |
$643.13 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,326 |
916 |
$576.69 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
32 |
14 |
$576.62 |
| 86038 |
|
41 |
39 |
$570.18 |
| 80349 |
|
30 |
24 |
$557.27 |
| 87486 |
|
12 |
12 |
$554.46 |
| 80159 |
|
90 |
73 |
$552.59 |
| 97166 |
|
15 |
12 |
$520.68 |
| 80348 |
|
15 |
12 |
$496.15 |
| 82746 |
|
40 |
36 |
$464.17 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
24 |
12 |
$450.52 |
| 77065 |
Tomosynthesis, mammo |
19 |
13 |
$443.40 |
| 72110 |
|
13 |
12 |
$415.53 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16 |
12 |
$379.81 |
| 84403 |
|
90 |
85 |
$346.44 |
| 36416 |
|
210 |
113 |
$342.25 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,002 |
796 |
$322.53 |
| 85007 |
|
59 |
42 |
$322.04 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
644 |
459 |
$291.56 |
| 80074 |
|
32 |
27 |
$285.72 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
96 |
79 |
$283.68 |
| 87581 |
|
12 |
12 |
$277.19 |
| 86706 |
|
43 |
40 |
$268.87 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
12 |
12 |
$225.26 |
| 87210 |
|
66 |
53 |
$208.08 |
| 82105 |
|
26 |
25 |
$182.96 |
| 97597 |
|
16 |
12 |
$167.31 |
| 87077 |
|
20 |
17 |
$152.57 |
| 86704 |
|
27 |
27 |
$151.41 |
| 84100 |
|
59 |
38 |
$133.31 |
| 86361 |
|
12 |
12 |
$131.02 |
| 85018 |
|
49 |
42 |
$113.72 |
| 88300 |
|
14 |
12 |
$103.34 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
39 |
31 |
$77.92 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
224 |
121 |
$72.23 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
26 |
26 |
$54.67 |
| 86364 |
|
33 |
27 |
$43.28 |
| 85014 |
|
12 |
12 |
$42.42 |
| 90686 |
|
20 |
17 |
$41.03 |
| J1644 |
Injection, heparin sodium, per 1000 units |
168 |
80 |
$21.67 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
18 |
12 |
$18.88 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
413 |
282 |
$17.22 |
| J3411 |
Injection, thiamine hcl, 100 mg |
36 |
27 |
$15.43 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
30 |
26 |
$8.92 |
| J2060 |
Injection, lorazepam, 2 mg |
285 |
210 |
$8.40 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
17 |
12 |
$6.39 |
| A9270 |
Non-covered item or service |
3,956 |
680 |
$5.13 |
| J1815 |
Injection, insulin, per 5 units |
35 |
13 |
$1.14 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
257 |
208 |
$0.00 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
13 |
12 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
91 |
78 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
148 |
127 |
$0.00 |
| A9698 |
Non-radioactive contrast imaging material, not otherwise classified, per study |
428 |
398 |
$0.00 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
81 |
80 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
12 |
$0.00 |